Skip to main content
. 2016 Aug 14;2016:3480629. doi: 10.1155/2016/3480629

Table 2.

Fasting blood sugar (FBS) and mean 2-hr postprandial blood sugar at start and throughout treatment (mg/dL).

Parameter Metformin group Insulin group P value
Mean fasting (FBS) (mg/dL) at starting of treatment 136.09 ± 39.85 137.56 ± 41.10 0.869
Mean 2-hr postprandial blood sugar at starting of treatment 198.32 ± 214.67 196.52 ± 15.45 0.451
Mean fasting (FBS) (mg/dL) throughout treatment 93.25 ± 13.7 94.33 ± 11.1 0.953
Mean 2-hr postprandial blood sugar throughout treatment 116.52 ± 3.53 117.12 ± 3.45 0.158